While reporting financial results for the third quarter on Friday, biopharmaceutical company AbbVie Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2021.
For fiscal 2021, AbbVie now projects earnings in a range of $6.29 to $6.33 per share and adjusted earnings in a range of $12.63 to $12.67 per share.
Previously, the company expected adjusted earnings in a range of $6.04 to $6.14 per share and adjusted earnings in a range of $12.52 to $12.62 per share.
On average, 19 analysts polled by Thomson Reuters expect the company to report earnings of $12.59 per share for the year. Analysts' estimates typically exclude special items.
Further, AbbVie announced that its board of directors declared a 8.5 percent higher quarterly cash dividend of $1.41 per share, beginning with the dividend payable on February 15, 2022 to shareholders of record as of January 14, 2022.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.